October 27, 2020

Former Deloitte CEO Will Squeeze in Pfizer Board Meetings in Addition to All That Public Service

Former Deloitte CEO Joe Echevarria will join Pfizer's board of directors effective immediately, according to a company press release. That's a decent gig!

The release also mentions that Joe E is on the board of Bank of New York Mellon. He landed that back in February and serves on the audit committee. Presumably, he'll serve on Pfizer's audit committee as well.

When he retired, Joe did say he was planning "to pursue my passion for public service," so you have to wonder if two seats on junk drawer committees will get in the way of his work with the President’s Export Council, the Presidential Commission on Election Administration, the President’s My Brother’s Keeper Alliance and the University of Miami. 

I just can't fathom going to all those meetings. But I'm sure Joe will be fine. It sure beats squabbling with real estate brokers

[Pfizer]

Latest Accounting Jobs--Apply Now:

Have something to add to this story? Give us a shout by email, Twitter, or text/call the tipline at 202-505-8885. As always, all tips are anonymous.

Comments are closed.

Related articles

Promotion Watch ’20: Deloitte Adds 195 New Managing Directors

Let’s pass out the cupcakes and green Kool-Aid, and celebrate Deloitte’s new class of managing directors for FY 2021: Bhawna Agarwal, Tax, Deloitte Tax LLP, Jersey City Jon Allred, Audit & Assurance, Deloitte & Touche LLP, Salt Lake City Aaron B. Bairani, Tax, Deloitte Tax LLP, Chicago Melissa Balmer, General Counsel, Deloitte LLP, Stamford Megan […]

Florida Gives Deloitte Consulting a Happy Ending

The saga between Florida and Deloitte Consulting—a relationship bizarre enough to be reported by TMZ or covered by Perez Hilton—keeps on keeping on, as the state’s Agency for Health Care Administration is going ahead with Big D on a potential $135 million contract to overhaul Florida’s Medicaid data system, according to the Tampa Bay Times. […]